Glycemic State as a Predictor of Adverse Cardiac Events in ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention versus Thrombolytic Therapy Among Non-Diabetic Patients
(2025). Glycemic State as a Predictor of Adverse Cardiac Events in ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention versus Thrombolytic Therapy Among Non-Diabetic Patients. EKB Journal Management System, 99(1), 2250-2256. doi: 10.21608/ejhm.2025.432243
. "Glycemic State as a Predictor of Adverse Cardiac Events in ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention versus Thrombolytic Therapy Among Non-Diabetic Patients". EKB Journal Management System, 99, 1, 2025, 2250-2256. doi: 10.21608/ejhm.2025.432243
(2025). 'Glycemic State as a Predictor of Adverse Cardiac Events in ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention versus Thrombolytic Therapy Among Non-Diabetic Patients', EKB Journal Management System, 99(1), pp. 2250-2256. doi: 10.21608/ejhm.2025.432243
Glycemic State as a Predictor of Adverse Cardiac Events in ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention versus Thrombolytic Therapy Among Non-Diabetic Patients. EKB Journal Management System, 2025; 99(1): 2250-2256. doi: 10.21608/ejhm.2025.432243